DealOnepot AI, a San Francisco-based company accelerating small-molecule synthesis, raised $13 million in a seed fundraising round led by Fifty Years with participation from Khosla Ventures, Speedinvest, and others.
More on TechCrunch →
SEED
11/22/2025
NanoZymeX, a Basel, Switzerland-based nanobiotech enzyme therapy platform,...
Flourish Care, a Boston-based women’s mental health platform, raised...
Cellbricks Therapeutics, a Berlin, Germany-based biofabricated tissue...
Bioniq, a London-based personalised health platform, was acquired for $150...
Terns Pharmaceuticals, Inc., a Foster City, CA-based leukemia therapy...
Ouro Medicines, a Cambridge, MA-based clinical-stage immunology biotech,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
